Antidepressants: placebos with side effects?

Carlat, Daniel
December 2010
CMAJ: Canadian Medical Association Journal;12/14/2010, Vol. 182 Issue 18, pE873
Book Review
The article reviews the book "The Emperor's New Drugs: Exploring the Antidepressant Myth," by Irving Kirsch.


Related Articles

  • The Emperor's New Drugs: Exploding the Antidepressant Myth. Guess, Pam // Ethical Human Psychology & Psychiatry;2011, Vol. 13 Issue 1, p83 

    The article reviews the book "The Emperor's New Drugs: Exploding the Antidepressant Myth," by Irving Kirsch.

  • The Emperor's New Drugs: Exploding the Antidepressant Myth. Hays, Carl // Booklist;2/15/2010, Vol. 106 Issue 12, p17 

    Reviews the book "The Emperor's New Drugs: Exploding the Antidepressant Myth," by Irving Kirsch.

  • Review: The Emperor's New Drugs by Irving Kirsch and Doctoring the Mind by Richard Bentall. Else, Liz // New Scientist;9/5/2009, Vol. 203 Issue 2724, p46 

    The article reviews the books "The Emperor's New Drugs: Exploding the Antidepressant Myth," by Irving Kirsch and "Doctoring the Mind," by Richard Bentall.

  • PROZAC VS. PLACEBOS. Noonan, David; Cowley, Geoffrey // Newsweek;7/15/2002, Vol. 140 Issue 3, p48 

    Focuses on the use of antidepressants by Americans, in light of a study by Irving Kirsch entitled 'The Emperor's New Drugs,' that argues that these pills may have no meaningful pharmacological effect at all. Finding of Kirsch that people who received placebos claimed to improve, supporting his...

  • Antidepressants only work in the most depressed patients.  // New Scientist;3/1/2008, Vol. 197 Issue 2645, p7 

    The article reports on the findings of a study that focused on the efficacy of antidepressants. The study showed that these drugs work better for those who are most severely depressed patients. According to researcher Irving Kirsch, antidepressants do not produce clinically significant...

  • Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration. Kirsch, Irving; Deacon, Brett J.; Huedo-Medina, Tania B.; Scoboria, Alan; Moore, Thomas J.; Johnson, Blair T. // PLoS Medicine;Feb2008, Vol. 5 Issue 2, pe45 

    Kirsch and colleagues show that, in antidepressant trials, there is a greater difference in efficacy between drug and placebo amongst more severely depressed patients. However, this difference seems to result from a poorer response to placebo amongst more depressed patients.

  • Depression Update.  // PharmaWatch: CNS;Apr2008, Vol. 7 Issue 4, p9 

    The article offers news briefs related to depression treatment. Biovail Corp.'s supplemental new drug submission of Wellbutrin XL for the prevention of major depressive illness was approved by Canada's Therapeutic Products Directorate. A study by Irving Kirsch with his group asserted that drugs...

  • News.  // Healthcare Counselling & Psychotherapy Journal;Apr2008, Vol. 8 Issue 2, p2 

    The article presents information on two news related to psychotherapy and antidepressants. It mentions that the proposed Improving Access To Psychological Therapies (IAPT) programme announced by the Dept. of Health of London, England, plans to train an extra 3,600 psychological therapists over...

  • Placebo Power: A Mystery Grows. Saxbe, Darby // Psychology Today;Sep/Oct2004, Vol. 37 Issue 5, p18 

    Focuses on studies regarding the effect of antidepressants on people taking placebo medications. Result of a clinical trial on placebo response to antidepressants among children conducted by University of Michigan researcher Jon-Kar Zubieta; Information on the findings of Columbia University...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics